Singapore markets closed
Straits Times Index
3,297.55 -26.98 (-0.81%) Nikkei
38,102.44 -712.12 (-1.83%) Hang Seng
17,936.56 -5.22 (-0.03%) FTSE 100
8,170.26 +23.40 (+0.29%) Bitcoin USD
66,210.49 -40.21 (-0.06%) CMC Crypto 200
1,392.99 +4.83 (+0.35%)
Vaxart, Inc. (NB11.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 09:10AM CEST. Market open.
| Previous close | 0.6925 |
| Open | 0.6195 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.6195 - 0.6295 |
| 52-week range | 0.5044 - 1.3300 |
| Volume | |
| Avg. volume | 462 |
| Market cap | 111.32M |
| Beta (5Y monthly) | 0.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Benzinga
Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering
Vaxart, Inc. (NASDAQ:VXRT) shares traded higher in the premarket session on Friday, up more than 23% at one point. Vaxart’s average session volume was about 1.6 million. Friday premarket’s session volume had exceeded four million at the time of writing. Yesterday, Vaxart obtained a project award worth $453 million through the Rapid Response Partnership Vehicle, supported by the Biomedical Advanced Research and Development Authority under the Administration for Strategic Preparedness and Response
- GuruFocus.com
Vaxart Inc (VXRT) Q1 2024 Earnings Call Transcript Highlights: Promising Developments and ...
Explore key financial outcomes, clinical trial updates, and strategic plans from Vaxart's latest earnings call.
© 2024 Yahoo. All rights reserved.